Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation.

BACKGROUND Normal pregnancy is associated with enhanced vasodilatation because of the increased nitric oxide (NO) production. Because L-homoarginine can act as a substrate for NO production, concentrations of L-homoarginine in normal pregnancy were assessed in the present study to test whether L-homoarginine is associated with endothelial function. METHODS AND RESULTS Healthy non-pregnant (n=61) and pregnant women (n=58) were studied in a cross-sectional study. L-homoarginine, L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine concentrations were determined simultaneously by high-performance liquid chromatography. Endothelium-dependent brachial artery flow-mediated dilation (FMD) was measured by ultrasound. The serum L-homoarginine concentration was significantly higher during the second and the third trimesters compared with the levels in the non-pregnant women (4.8+/-1.7 and 5.3+/-1.5 vs 2.7+/-1.0 micromol/L, p<0.001, respectively). In line with this, FMD increased in response to pregnancy (p<0.05). Three months after delivery, the L-homoarginine concentrations and FMD were comparable to those recorded in the non-pregnant females. The concentration of L-homoarginine correlated significantly with gestational age (r=0.426, p=0.001) and brachial artery diameter and FMD (r=0.362, p=0.006 and r=0.306, p=0.022, respectively) in pregnancy. CONCLUSIONS L-homoarginine appears to be increased during the second and third trimesters of pregnancy and may contribute to the enhanced endothelial function in normal pregnancies.

[1]  T. Laitinen,et al.  Subtle changes in ADMA and l‐arginine concentrations in normal pregnancies are unlikely to account for pregnancy‐related increased flow‐mediated dilatation , 2008, Clinical physiology and functional imaging.

[2]  U. Förstermann,et al.  Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. , 2008, Clinical chemistry.

[3]  T. Lehtimäki,et al.  Relation of apolipoprotein E polymorphism to markers of early atherosclerotic changes in young adults--the Cardiovascular Risk in Young Finns Study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[4]  T. Laitinen,et al.  Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study , 2007, Circulation.

[5]  J. Ribalta,et al.  Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[6]  D. Talwar,et al.  Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma , 2007, European journal of clinical investigation.

[7]  A. Esen,et al.  Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[8]  T. Laitinen,et al.  Pregnancy-related hyperlipidemia and endothelial function in healthy women. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[9]  Hyung-Suk Kim,et al.  Amino acids as modulators of endothelium-derived nitric oxide. , 2006, American journal of physiology. Renal physiology.

[10]  T. Halonen,et al.  Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  R. Magness,et al.  Simultaneous imaging of [Ca2+]i and intracellular NO production in freshly isolated uterine artery endothelial cells: effects of ovarian cycle and pregnancy. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[12]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[13]  E. Benjamin,et al.  Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community: The Framingham Heart Study , 2004, Circulation.

[14]  Yunfeng Zhu,et al.  Estrogen modulates the expression of L‐arginine:glycine amidinotransferase in chick liver , 2001, Molecular and Cellular Biochemistry.

[15]  G. D. Johnston,et al.  Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[16]  A. Ignaszewski,et al.  The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. , 2003, Journal of the American College of Cardiology.

[17]  A. Hingorani,et al.  Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia , 2003, The Lancet.

[18]  R. Magness,et al.  Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  G. Pacini,et al.  Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes , 2002, Diabetologia.

[20]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[21]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[22]  B. Kingwell,et al.  Variations in endothelial function and arterial compliance during the menstrual cycle. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  M. Denton,et al.  Dimethylarginines in chronic renal failure , 2001, Journal of clinical pathology.

[24]  H. Knapp,et al.  Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. , 2001, Clinical science.

[25]  J. Pi,et al.  Improved method for simultaneous determination of L-arginine and its mono- and dimethylated metabolites in biological samples by high-performance liquid chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[26]  D. Tsikas,et al.  Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography-mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[27]  P. Tsao,et al.  Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  D. Rousseau,et al.  Stopped-flow analysis of substrate binding to neuronal nitric oxide synthase. , 1999, Biochemistry.

[29]  P. Vallance,et al.  Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. , 1999, Cardiovascular research.

[30]  K. Sørensen,et al.  Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. , 1999, American journal of physiology. Heart and circulatory physiology.

[31]  S. Nussey,et al.  Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. , 1998, American journal of obstetrics and gynecology.

[32]  L. Poston,et al.  Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. , 1997, Hypertension.

[33]  V. Ravindran,et al.  Homoarginine influences voluntary feed intake, tissue basic amino acid concentrations and arginase activity in chickens. , 1997, Journal of NutriLife.

[34]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[35]  A. Hrabák,et al.  Comparison of substrate and inhibitor specificity of arginase and nitric oxide (NO) synthase for arginine analogues and related compounds in murine and rat macrophages. , 1994, Biochemical and biophysical research communications.

[36]  P. Sanders,et al.  Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. , 1993, Hypertension.

[37]  P. D. De Deyn,et al.  Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. , 1992, Metabolism: clinical and experimental.

[38]  J. Vane,et al.  On the substrate specificity of nitric oxide synthase , 1991, FEBS letters.

[39]  R. Bhardwaj,et al.  The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney , 1989, British journal of pharmacology.

[40]  J. Viikari,et al.  Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross‐sectional study of 1980, and an account of the children's and families' state of health , 1985, Acta paediatrica Scandinavica. Supplement.

[41]  N. Fujimoto,et al.  Fluorometrical Analysis of Guanidino Compounds in Human Cerebrospinal Fluid , 1982, Journal of neurochemistry.

[42]  W. El-Deiry,et al.  Stabilization of proteins by guanidination. , 1980, The Journal of biological chemistry.

[43]  R. Johnson,et al.  Homoarginine synthesis by rat kidney. , 1969, Archives of biochemistry and biophysics.

[44]  I. Wells,et al.  Homocitrulline and Homoarginine Synthesis from Lysine , 1964, Science.

[45]  T. Gerritsen,et al.  On the isolation and identification of homocitrulline from urine. , 1961, Biochemical and biophysical research communications.